BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1
136 results:

  • 1. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.
    Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L
    Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas.
    Bildik G; Gray JP; Mao W; Yang H; Ozyurt R; Orellana VR; De Wever O; Carey MS; Bast RC; Lu Z
    Autophagy; 2024 Mar; 20(3):675-691. PubMed ID: 38169324
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effects of Autophagy-Related Genes on the Prognosis and Immune Microenvironment of ovarian cancer.
    Zhang J; Yan H; Fu Y
    Biomed Res Int; 2022; 2022():6609195. PubMed ID: 35941978
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer.
    Zong S; Xu PP; Xu YH; Guo Y
    J Ovarian Res; 2022 Aug; 15(1):90. PubMed ID: 35915456
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PUMILIO-mediated translational control of somatic cell cycle program promotes folliculogenesis and contributes to ovarian cancer progression.
    Li X; Zhu M; Zang M; Cao D; Xie Z; Liang H; Bian Z; Zhao T; Hu Z; Xu EY
    Cell Mol Life Sci; 2022 May; 79(5):279. PubMed ID: 35507203
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Damnacanthal isolated from morinda species inhibited ovarian cancer cell proliferation and migration through activating autophagy.
    Li R; Li H; Lan J; Yang D; Lin X; Xu H; Han B; Yang M; Su B; Liu F; Jiang W
    Phytomedicine; 2022 Jun; 100():154084. PubMed ID: 35421676
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Caffeic acid phenethyl ester targets ubiquitin-specific protease 8 and synergizes with cisplatin in endometrioid ovarian carcinoma cells.
    Colombo D; Gatti L; Sjöstrand L; Carenini N; Costantino M; Corna E; Arrighetti N; Zuccolo M; De Cesare M; Linder S; D'Arcy P; Perego P
    Biochem Pharmacol; 2022 Mar; 197():114900. PubMed ID: 34995485
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Postoperative outcomes of primary and interval cytoreductive surgery for advanced ovarian cancer registered in the Dutch Gynecological Oncology Audit (DGOA).
    Baldewpersad Tewarie NMS; van Driel WJ; van Ham M; Wouters MW; Kruitwagen R;
    Gynecol Oncol; 2021 Aug; 162(2):331-338. PubMed ID: 34147284
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistance.
    Zong X; Zhang Y; Peng X; Cao D; Yu M; Wang J; Li H; Guo X; Liang H; Yang J
    Nat Commun; 2021 Jun; 12(1):3579. PubMed ID: 34117242
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Trichodermin Induces G0/G1 Cell Cycle Arrest by Inhibiting c-Myc in ovarian cancer Cells and Tumor Xenograft-Bearing Mice.
    Gao Y; Miles SL; Dasgupta P; Rankin GO; Cutler S; Chen YC
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34065149
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube.
    Dinh HQ; Lin X; Abbasi F; Nameki R; Haro M; Olingy CE; Chang H; Hernandez L; Gayther SA; Wright KN; Aspuria PJ; Karlan BY; Corona RI; Li A; Rimel BJ; Siedhoff MT; Medeiros F; Lawrenson K
    Cell Rep; 2021 Apr; 35(2):108978. PubMed ID: 33852846
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The Selectivity for Tumor Cells of Nuclear-Directed Cytotoxic RNases Is Mediated by the Nuclear/Cytoplasmic Distribution of p27
    García-Galindo G; Castro J; Matés J; Bravo M; Ribó M; Vilanova M; Benito A
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33801209
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. cdkn1b mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
    Viotto D; Russo F; Anania I; Segatto I; Rampioni Vinciguerra GL; Dall'Acqua A; Bomben R; Perin T; Cusan M; Schiappacassi M; Gerratana L; D'Andrea S; Citron F; Vit F; Musco L; Mattevi MC; Mungo G; Nicoloso MS; Sonego M; Massarut S; Sorio R; Barzan L; Franchin G; Giorda G; Lucia E; Sulfaro S; Giacomarra V; Polesel J; Toffolutti F; Canzonieri V; Puglisi F; Gattei V; Vecchione A; Belletti B; Baldassarre G
    J Pathol; 2021 Feb; 253(2):234-245. PubMed ID: 33140857
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Assessing and validating housekeeping genes in normal, cancerous, and polycystic human ovaries.
    Asiabi P; Ambroise J; Giachini C; Coccia ME; Bearzatto B; Chiti MC; Dolmans MM; Amorim CA
    J Assist Reprod Genet; 2020 Oct; 37(10):2545-2553. PubMed ID: 32729067
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Exosomes released from M2 macrophages transfer miR-221-3p contributed to EOC progression through targeting cdkn1b.
    Li X; Tang M
    Cancer Med; 2020 Aug; 9(16):5976-5988. PubMed ID: 32590883
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.
    Caslini C; Hong S; Ban YJ; Chen XS; Ince TA
    Oncogene; 2019 Sep; 38(39):6599-6614. PubMed ID: 31375747
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. RUNX3 Promotes the Tumorigenic Phenotype in KGN, a Human Granulosa Cell Tumor-Derived Cell Line.
    Chen H; Crosley P; Azad AK; Gupta N; Gokul N; Xu Z; Weinfeld M; Postovit LM; Pangas SA; Hitt MM; Fu Y
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311113
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Nodal induces apoptosis and inhibits proliferation in ovarian endometriosis-clear cell carcinoma lesions.
    Miura R; Yokoi A; Matsumoto T; Oguri Y; Hashimura M; Tochimoto M; Kajita S; Saegusa M
    BMC Cancer; 2019 Apr; 19(1):308. PubMed ID: 30943930
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer.
    Secord AA; McCollum M; Davidson BA; Broadwater G; Squatrito R; Havrilesky LJ; Gabel AC; Starr MD; Brady JC; Nixon AB; Duska LR
    Gynecol Oncol; 2019 Jun; 153(3):555-561. PubMed ID: 30929823
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Deletion of cdkn1b in ACI rats leads to increased proliferation and pregnancy-associated changes in the mammary gland due to perturbed systemic endocrine environment.
    Ding L; Shunkwiler LB; Harper NW; Zhao Y; Hinohara K; Huh SJ; Ekram MB; Guz J; Kern MJ; Awgulewitsch A; Shull JD; Smits BMG; Polyak K
    PLoS Genet; 2019 Mar; 15(3):e1008002. PubMed ID: 30893315
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.